Literature DB >> 30415275

A reply to Henningfield, Fant & Wang (2018): regulatory action to control kratom is long overdue.

David V Gauvin1, Zachary J Zimmermann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30415275     DOI： 10.1007/s00213-018-5112-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  16 in total

1.  Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.

Authors:  Scott E Hemby; Scot McIntosh; Francisco Leon; Stephen J Cutler; Christopher R McCurdy
Journal:  Addict Biol       Date:  2018-06-27       Impact factor: 4.280

2.  Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats.

Authors:  Nurul H M Yusoff; Sharif M Mansor; Christian P Müller; Zurina Hassan
Journal:  Behav Brain Res       Date:  2017-05-27       Impact factor: 3.332

Review 3.  From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction.

Authors:  Zurina Hassan; Mustapha Muzaimi; Visweswaran Navaratnam; Nurul H M Yusoff; Farah W Suhaimi; Rajakumar Vadivelu; Balasingam K Vicknasingam; Davide Amato; Stephan von Hörsten; Nurul I W Ismail; Nanthini Jayabalan; Ammar I Hazim; Sharif M Mansor; Christian P Müller
Journal:  Neurosci Biobehav Rev       Date:  2012-12-01       Impact factor: 8.989

Review 4.  Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa.

Authors:  Hiromitsu Takayama
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-08       Impact factor: 1.645

Review 5.  Kratom use and mental health: A systematic review.

Authors:  Marc T Swogger; Zach Walsh
Journal:  Drug Alcohol Depend       Date:  2017-12-07       Impact factor: 4.492

6.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

7.  Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Jun Lu; Heming Wei; Jianjun Wu; Mohd Fadzly Amar Jamil; Mei Lan Tan; Mohd Ilham Adenan; Philip Wong; Winston Shim
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

Review 8.  The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.

Authors:  Jack E Henningfield; Reginald V Fant; Daniel W Wang
Journal:  Psychopharmacology (Berl)       Date:  2017-12-23       Impact factor: 4.530

9.  Kratom: a dangerous player in the opioid crisis.

Authors:  Khadija Tayabali; Colin Bolzon; Paul Foster; Janki Patel; Mohammad Omar Kalim
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-06-12

10.  Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to 'kratom'.

Authors:  L Davidson; M Rawat; S Stojanovski; P Chandrasekharan
Journal:  J Neonatal Perinatal Med       Date:  2019
View more
  2 in total

1.  Cardiac arrest in a young healthy male patient secondary to kratom ingestion: is this 'legal high' substance more dangerous than initially thought ?

Authors:  Hafez Mohammad Ammar Abdullah; Iqra Haq; Randall Lamfers
Journal:  BMJ Case Rep       Date:  2019-07-19

2.  Kratom policy: The challenge of balancing therapeutic potential with public safety.

Authors:  Walter C Prozialeck; Bonnie A Avery; Edward W Boyer; Oliver Grundmann; Jack E Henningfield; Andrew C Kruegel; Lance R McMahon; Christopher R McCurdy; Marc T Swogger; Charles A Veltri; Darshan Singh
Journal:  Int J Drug Policy       Date:  2019-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.